David Bennett to Adolescent
This is a "connection" page, showing publications David Bennett has written about Adolescent.
Connection Strength
0.324
-
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
Score: 0.071
-
Pre- and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score. Acta Neurochir (Wien). 2020 10; 162(10):2371-2379.
Score: 0.029
-
Association Between High School Personality Phenotype and Dementia 54 Years Later in Results From a National US Sample. JAMA Psychiatry. 2020 02 01; 77(2):148-154.
Score: 0.028
-
Genome-wide association studies of alcohol dependence, DSM-IV criterion count and individual criteria. Genes Brain Behav. 2019 07; 18(6):e12579.
Score: 0.027
-
Disentangling the genetics of lean mass. Am J Clin Nutr. 2019 02 01; 109(2):276-287.
Score: 0.026
-
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 05 29; 9(1):2098.
Score: 0.025
-
Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 01 18; 8:13624.
Score: 0.023
-
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan. Mol Psychiatry. 2014 Oct; 19(10):1125-32.
Score: 0.018
-
Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
Score: 0.017
-
A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol. 2012 Sep; 72(3):324-34.
Score: 0.017
-
Association between cognitive activity and cognitive function in older Hispanics. J Int Neuropsychol Soc. 2012 Nov; 18(6):1041-51.
Score: 0.016
-
Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
Score: 0.011
-
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.
Score: 0.010
-
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 1999 Mar 10; 52(4):732-7.
Score: 0.007